Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Open Label, Efficacy and Safety Study of Parenteral SAR97276A in the Treatment of Symptomatic Uncomplicated and Severe Malaria in Adults and Children

NCT00739206 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT00739206
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00739206 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Open Label, Efficacy and Safety Study of Parenteral SAR97276A in the Treatment of Symptomatic Uncomplicated and Severe Malaria in Adults and Children
Lead sponsor
Sanofi
Phase
Phase 2
Overall status
Terminated
Start date
August 31, 2008
Completion date
June 30, 2009
Enrollment
113 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

malaria